Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 5
1990 5
1991 2
1992 3
1993 2
1994 3
1995 2
1996 4
1997 3
1998 3
1999 7
2000 4
2001 4
2002 3
2003 2
2004 2
2005 6
2006 4
2007 5
2008 2
2009 2
2010 2
2011 1
2012 1
2013 6
2014 13
2015 7
2016 10
2017 5
2018 3
2019 7
2020 3
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

120 results
Results by year
Filters applied: . Clear all
Page 1
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan AH, Kamat S, Maroni J, Rowe P, Lu Y, Amin N, Pirozzi G, Ruddy M, Graham NMH, Teper A. Corren J, et al. Among authors: o riordan t. J Allergy Clin Immunol Pract. 2020 Feb;8(2):516-526. doi: 10.1016/j.jaip.2019.08.050. Epub 2019 Sep 12. J Allergy Clin Immunol Pract. 2020. PMID: 31521831 Free article. Clinical Trial.
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
Busse WW, Wenzel SE, Casale TB, FitzGerald JM, Rice MS, Daizadeh N, Deniz Y, Patel N, Harel S, Rowe PJ, Graham NMH, O'Riordan T, Pavord ID. Busse WW, et al. Among authors: o riordan t. Lancet Respir Med. 2021 Oct;9(10):1165-1173. doi: 10.1016/S2213-2600(21)00124-7. Epub 2021 Jun 25. Lancet Respir Med. 2021. PMID: 34181876
Inhaled antimicrobial therapy.
O'Riordan T, Faris M. O'Riordan T, et al. Respir Care Clin N Am. 1999 Dec;5(4):617-31. Respir Care Clin N Am. 1999. PMID: 10565884 Review.
Treatment of mucociliary dysfunction.
Salathe M, O'Riordan TG, Wanner A. Salathe M, et al. Among authors: o riordan tg. Chest. 1996 Oct;110(4):1048-57. doi: 10.1378/chest.110.4.1048. Chest. 1996. PMID: 8874267 Free article. Review. No abstract available.
Formulations and nebulizer performance.
O'Riordan TG. O'Riordan TG. Respir Care. 2002 Nov;47(11):1305-12; discussion 1312-3. Respir Care. 2002. PMID: 12425745 Review.
Risk factors for disease progression in idiopathic pulmonary fibrosis.
Raghu G, Ley B, Brown KK, Cottin V, Gibson KF, Kaner RJ, Lederer DJ, Noble PW, Song JW, Wells AU, Whelan TP, Lynch DA, Humphries SM, Moreau E, Goodman K, Patterson SD, Smith V, Gong Q, Sundy JS, O'Riordan TG, Martinez FJ. Raghu G, et al. Among authors: o riordan tg. Thorax. 2020 Jan;75(1):78-80. doi: 10.1136/thoraxjnl-2019-213620. Epub 2019 Oct 14. Thorax. 2020. PMID: 31611341
Mucociliary clearance in the airways.
Wanner A, Salathé M, O'Riordan TG. Wanner A, et al. Among authors: o riordan tg. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1868-902. doi: 10.1164/ajrccm.154.6.8970383. Am J Respir Crit Care Med. 1996. PMID: 8970383 Review. No abstract available.
120 results